Skip to main content

Anxiety Disorders

  • Living reference work entry
  • First Online:
Family Medicine

Abstract

Anxiety disorders are characterized by an excessive fear response; these disorders are extremely prevalent among the general population and have a 2:1 female predilection [1]. Functional impairment is common with these disorders and, along with depression, is among the leading causes of disability and work-related absences. As such, it is postulated that the economic burden of anxiety disorders is greater than any other psychiatric disorder, due to the high prevalence and cost of medical and psychiatric treatment [2]. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), defines fear as “the emotional response to real or perceived imminent threat” and anxiety as “anticipation of future threat.” Fear typically induces surges of autonomic arousal and thoughts of immediate danger and escape, whereas anxiety typically manifests as muscular tension and avoidant behaviors. The anxiety disorders listed in the DSM-5 tend to be highly comorbid with other psychiatric conditions [1]. The DSM-5 chapter on Anxiety Disorders no longer includes obsessive-compulsive disorders, post-traumatic stress disorder, or acute stress disorder, which had been included in this section in the DSM-IV/DSM-IV-TR. Due to their relevance, these associated disorders will be discussed briefly in this chapter. Relevant changes to anxiety disorders in the DSM-5 are outlined in Table 1. Of note, the DSM-5 requires a minimum of 6-month duration of symptoms that are not attributable to another medical condition and mental disorder or induced by a substance or medication to meet diagnostic criteria for anxiety disorders. An exception is noted in symptom duration for children with separation anxiety disorder and selective mutism, with a required duration of 4 weeks and 1 month, respectively. Panic disorder and agoraphobia have been unlinked in the DSM-5, and panic attacks can now be listed as a specifier, applicable to all DSM-5 disorders [1]. Many anxiety disorders develop in early childhood and typically persist into adulthood if not adequately treated. These disorders differ from developmentally normative fear or anxiety in magnitude of reaction and/or persistence beyond developmentally appropriate periods. A thorough grasp of a proper differential diagnosis and treatment of anxiety disorders can be daunting; however, it may be easier to conceptualize various anxiety disorders from the perspective of the developmental spectrum, using age of onset to help guide a differential [1, 3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013. p. 607–913.

    Google Scholar 

  2. Garakani A, Murrough J, Iosifescu D. Advances in psychopharmacology for anxiety disorders. Focus. 2014;XII(2):152–62.

    Article  Google Scholar 

  3. Allgulander C. Morbid anxiety as a risk factor in patients with somatic diseases: a review of recent findings. Mind Brain. 2010; 1–9.

    Google Scholar 

  4. Wong P. Selective mutism: a review of etiology, comorbidities, and treatment. Psychiatry. 2010;7(3):23–31.

    PubMed Central  PubMed  Google Scholar 

  5. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655.

    Article  CAS  PubMed  Google Scholar 

  6. Lenze EJ. Anxiety disorders in the elderly. In: Stein DJ, Hollander E, Rothbaum BO, editors. Textbook of anxiety disorders, vol. 2. Washington, DC: American Psychiatric Publishing; 2010. p. 651.

    Google Scholar 

  7. Scneider F, Milrod B. Gabbard’s treatments of psychiatric disorders. 5th ed. American Psychiatric Publishing, Arlington; 2014.

    Google Scholar 

  8. Grant JE, Odlaug BA, Won KS. N-Acetylcysteine, a glutamate modulator, in the treatment of Trichotillomania. Arch Gen Psychiatry. 2009;66(7):756–63.

    Article  CAS  PubMed  Google Scholar 

  9. Koran LM, Simpson HB. Guideline watch: practice guidelines for the treatment of patients with obsessive-compulsive disorder. APA Pract Guidel. 2013; 1–22.

    Google Scholar 

  10. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.

    Article  CAS  PubMed  Google Scholar 

  11. Koerner N, Antony M, Dugas M. Limitations of the Hamilton Anxiety Rating Scale as a primary outcome measure in randomized, controlled trials of treatments for generalized anxiety disorder. Am J Psychiatry. 2010;167(1):103–4.

    Article  PubMed  Google Scholar 

  12. Spitzer RL, Kroenke K, Willimas JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.

    Article  PubMed  Google Scholar 

  13. Cupp M. Pharmacotherapy of anxiety disorders. Prescriber’s Lett. 2014; PL Detail-Doc #301006: 1–5.

    Google Scholar 

  14. Finley PR, Lee KC. Mood disorders 1: major depressive disorders. In: Alldredge BK, Corelli RL, Ernst ME, et al., editors. Koda-Kimble and Young’s applied therapeutics; the clinical use of drugs. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1949–82.

    Google Scholar 

  15. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: American Psychiatric Association Publishing; 2010.

    Google Scholar 

  16. Sarris J, Stough C, Bousman C. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2013;33(5):643–8.

    Article  PubMed  Google Scholar 

  17. Sharma M. Yoga as an alternative and complementary approach for stress management: a systematic review. J Evid Based Complementary Altern Med. 2014;19:59–67.

    Article  PubMed  Google Scholar 

  18. Salmon P. Effects of physical exercise on anxiety, depression, and sensitivity to stress: a unifying theory. Clin Psychol Rev. 2001;21(1):33–61.

    Article  CAS  PubMed  Google Scholar 

  19. Bazzan A, Zabrecky G, Monti D, Newberg A. Current evidence regarding the management of mood and anxiety disorders using complementary and alternative medicine. Neurotherapeutics. 2014;14(4):411–23.

    Article  CAS  Google Scholar 

  20. Sharma M, Rush SE. Mindfulness-based stress reduction as a stress management intervention for healthy individuals: a systematic review. J Evid Based Complementary Altern Med. 2014;19(4):271–86.

    Article  PubMed  Google Scholar 

  21. Morgan LP, Graham JR, Hayes-Skelton SA, Orsillo SM, Roemer L. Relationships between amount of post-intervention of mindfulness practice and follow-up outcome variables in an acceptance-based behavior therapy for generalized anxiety disorder: the importance of informal practice. J Contextual Behav Sci. 2014;3(3):173–6.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Kessler RC, Gruber M, Hettma JM, et al. Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey Follow-up. Psychol Med. 2008;38:365.

    PubMed Central  CAS  PubMed  Google Scholar 

  23. Cuijpers P, Sijbrandij M, Koole S, Andersson G, Beekman A, Reynolds C. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. Focus. 2014;XII(3):347–58.

    Article  Google Scholar 

  24. Hoepner C. OTC Agents for depression, anxiety, and insomnia. Carlat Rep Psychiatr 2013; 11(7):1–3.

    Google Scholar 

  25. Mohatt J, Bennett S, Walkup J. Treatment of separation, generalized, and social anxiety disorders in youths. Am J Psychiatry. 2014;171:7.

    Article  Google Scholar 

  26. Bezchlibnyk-Butler K, Jeffries J, Procyshyn R, Virani A. Anxiolytic agents. In: Clinical handbook of psychotropic drugs. 20th ed. 2014. Boston: Hogrefe Publishing, pp. 196–212.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Phyllis MacGilvray .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland (outside the USA)

About this entry

Cite this entry

MacGilvray, P., Williams, R., Dambro, A. (2015). Anxiety Disorders. In: Paulman, P., Taylor, R. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-1-4939-0779-3_32-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0779-3_32-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-1-4939-0779-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics